National Centre for Clinical Research on Emerging Drugs
ORCID: 0000-0003-0215-3249Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP‐C Treatment as Prevention Study in Prisons”.
Jack Stone, Behzad Hajarizadeh, Marianne Byrne, Georgina Chambers, Natasha K. Martin +5 more